← All stocks

KIORA PHARMACEUTICALS INC

KPRX Net buying

CIK 0001372514 #5217 in the set updated 21 Sep 2026

Bought (120 mo)

$15.81M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$15.30M

$0.00 on a plan · $12.11M straight out of an exercise

Sold at will

$3.19M

23 of 28 sales

Net

+$506.27K

+$12.62M against sales at will

By person

19 insiders · 159 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

ARMISTICE CAPITAL, LLC entity

10% owner

$15.67M (111)

$15.19M (9) scheduled

+$472.88K

7,478,202

—

$27.52M

—

GOLDBERG MORTON

Director

—

$48.93K (3)

−$48.93K

0.0000%

$0.00

—

Strem Brian M.

President and CEO

$40.17K (2)

—

+$40.17K

58,823

1.33%

$216.47K

—

Parsons Erin

Director

$25.67K (1)

—

+$25.67K

5,260

0.1189%

$19.36K

—

TYLE PRAVEEN

Director

$19.80K (1)

—

+$19.80K

5,014

0.1133%

$18.45K

—

FROM STEPHEN

Executive Chairman

$12.88K (3)

$30.11K (3)

−$17.23K

67,693

1.53%

$249.11K

—

Ventech Capital II entity

10% owner

—

$12.38K (1)

−$12.38K

1,431,814

32.36%

$5.27M

−0.3%

Shapiro Aron

Director

$10.80K (1)

—

+$10.80K

3,000

0.0678%

$11.04K

—

Daniels Eric Joseph

Chief Development Officer

$7.57K (1)

—

+$7.57K

31,741

0.7174%

$116.81K

—

Tosca Melissa

CFO

$6.95K (2)

—

+$6.95K

26,064

0.5891%

$95.92K

—

Romano Sarah

Chief Financial Officer

$10.00K (3)

$4.67K (3)

+$5.33K

22,746

0.5141%

$83.71K

—

Walters-Hoffert Lisa

Director

$4.83K (1)

—

+$4.83K

1,250

0.0283%

$4.60K

—

MANZO MICHAEL P.

VP of Engineering

—

$4.67K (3)

−$4.67K

15,378

0.3476%

$56.59K

—

Wirostko Barbara

Chief Medical Officer

—

$4.60K (3)

−$4.60K

463,808

10.48%

$1.71M

+210.2%

Stengone Carmine N.

Director

$4.60K (1)

—

+$4.60K

1,250

0.0283%

$4.60K

—

Mann Brenda

VP of Research & Development

—

$4.50K (3)

−$4.50K

15,136

0.3421%

$55.70K

—

Garanzini Michael

Chief Commercial Officer

— (1)

—

$0.00

196,250

4.44%

$722.20K

—

CHANEY PAUL G

Director

—

91,229

2.06%

$335.72K

+285.6%

MALFROY-CAMINE BERNARD

Director

—

61,525

1.39%

$226.41K

+433.8%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 296

Amendments (4/A) skipped 3

Filings about a different issuer 0

Unreadable filings 0

Joint filings 16

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 5

Sales at will 23

Transactions with no price 5

Shares from compensation/vesting 3,253,681

Sales filed before the plan box existed 23

History held since 16 Sep 2016